Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape
{{output}}
Triple-negative breast cancer (TNBC) is characterized by the lack of estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor 2 overexpression. Historically, treatment options for TNBC have been limited, because of the absence ... ...
